Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma-Reference-Cited by-同舟云学术

Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma

Published:2019-02 Issue: Volume:128 Page:127-133
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Abel Stephen,Hasan Shaakir^ORCID,White Richard,Schumacher Lana,Finley Gene,Colonias Athanasios,Wegner Rodney E.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference40 articles.

1. Lung and Bronchus Cancer - Cancer Stat Facts. https://seer.cancer.gov/statfacts/html/lungb.html. Accessed 11 October 2018.

2. Sublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study;Liu;World J. Surg. Oncol.,2014

3. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy;Potters;Int. J. Radiat. Oncol.,2010

4. Stereotactic body radiation therapy for inoperable early stage lung Cancer;Timmerman;JAMA,2010

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of chest CT-scans following lung stereotactic ablative radiotherapy: Challenges and new insights;Lung Cancer;2024-07

2. Survival analysis after stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a single-institution cohort study;Radiation Oncology;2024-04-18

3. Long-Term Survival and Failure Outcomes of Single-Fraction Stereotactic Body Radiation Therapy in Early Stage NSCLC;JTO Clinical and Research Reports;2023-12

4. Impact of 0.35 T Magnetic Field on Dose Calculation for Non-small Cell Lung Cancer Stereotactic Radiotherapy Plans;Journal of Radiation Protection and Research;2023-09-30

5. Pathologic Nodal Staging Before SBRT for Early-stage NSCLC Does Not Impact Overall Survival;American Journal of Clinical Oncology;2023-09-08